Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

The effects of dosage time and frequency on motor outcomes in children with cerebral palsy: A systematic review.

Cope S, Mohn-Johnsen S.

Dev Neurorehabil. 2017 Feb 16:1-12. doi: 10.1080/17518423.2017.1282053. [Epub ahead of print]

PMID:
28632463
2.

2017 AMCA Presidential Address: Remarks On Leadership and the AMCA.

Cope SE.

J Am Mosq Control Assoc. 2017 Jun;33(2):87-90. doi: 10.2987/17-6657.1. No abstract available.

PMID:
28590227
3.

A seizure-induced T8 burst fracture re-presenting as an acute abdomen.

Smith RAJ, Poland N, Cope S.

BMJ Case Rep. 2017 May 12;2017. pii: bcr-2017-220346. doi: 10.1136/bcr-2017-220346.

PMID:
28500130
4.

Evaluation of a pilot innovative cognitive-behavioral therapy-based psychoeducation group treatment for functional non-epileptic attacks.

Cope SR, Smith JG, King T, Agrawal N.

Epilepsy Behav. 2017 May;70(Pt A):238-244. doi: 10.1016/j.yebeh.2017.02.014. Epub 2017 Apr 25.

PMID:
28454061
5.

Factors Associated With Publication Impact at Shoulder and Elbow Surgery Fellowships.

Cope SR, Holliday EB, Somerson JS.

J Surg Educ. 2017 Mar 1. pii: S1931-7204(16)30173-8. doi: 10.1016/j.jsurg.2017.02.008. [Epub ahead of print]

PMID:
28259487
6.

Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis.

Burnett H, Earley A, Voors AA, Senni M, McMurray JJ, Deschaseaux C, Cope S.

Circ Heart Fail. 2017 Jan;10(1). pii: e003529. doi: 10.1161/CIRCHEARTFAILURE.116.003529. Review.

7.

Use of Immunosuppressive Medications for Treatment of Pediatric Intermediate Uveitis.

Hersh AO, Cope S, Bohnsack JF, Shakoor A, Vitale AT.

Ocul Immunol Inflamm. 2016 Dec 14:1-9. doi: 10.1080/09273948.2016.1255340. [Epub ahead of print]

PMID:
27960602
8.

Publication Productivity and Experience: Factors Associated with Academic Rank Among Orthopaedic Surgery Faculty in the United States.

Ence AK, Cope SR, Holliday EB, Somerson JS.

J Bone Joint Surg Am. 2016 May 18;98(10):e41. doi: 10.2106/JBJS.15.00757. Review.

PMID:
27194503
9.

Congenital pseudoarthrosis in a child with neurofibromatosis.

Stammers K, Cope S.

BMJ Case Rep. 2015 Dec 15;2015. pii: bcr2015212813. doi: 10.1136/bcr-2015-212813. No abstract available.

PMID:
26670897
10.

Ensuring that 'hard to reach' young people agree to health assessments.

Cope S.

Nurs Child Young People. 2015 Dec;27(10):26-31. doi: 10.7748/ncyp.27.10.26.s27.

PMID:
26654027
11.

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.

Gupta JK, Daniels JP, Middleton LJ, Pattison HM, Prileszky G, Roberts TE, Sanghera S, Barton P, Gray R, Kai J; ECLIPSE Collaborative Group.

Health Technol Assess. 2015 Oct;19(88):i-xxv, 1-118. doi: 10.3310/hta19880.

12.

HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis.

Angeles-Han ST, McCracken C, Yeh S, Jang SR, Jenkins K, Cope S, Bohnsack J, Hersh A, Thompson SD, Prahalad S.

Invest Ophthalmol Vis Sci. 2015 Sep;56(10):6043-8. doi: 10.1167/iovs.15-17168.

13.

Slow Internal Dynamics and Charge Expansion in the Disordered Protein CGRP: A Comparison with Amylin.

Sizemore SM, Cope SM, Roy A, Ghirlanda G, Vaiana SM.

Biophys J. 2015 Sep 1;109(5):1038-48. doi: 10.1016/j.bpj.2015.07.023.

14.

Network meta-analysis of longitudinal data using fractional polynomials.

Jansen JP, Vieira MC, Cope S.

Stat Med. 2015 Jul 10;34(15):2294-311. doi: 10.1002/sim.6492. Epub 2015 Apr 15.

PMID:
25877808
15.

Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.

Cope S, Clemens A, Hammès F, Noack H, Jansen JP.

Value Health. 2015 Mar;18(2):234-49. doi: 10.1016/j.jval.2014.10.012. Epub 2015 Jan 28. Review.

16.

Systematic Review of Observational Studies and Rcts of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment.

Bergrath E, Hwa Ong S, Bousquet J, Balwin M, Manga V, Rao S, Cope S.

Value Health. 2014 Nov;17(7):A589. doi: 10.1016/j.jval.2014.08.2014. Epub 2014 Oct 26. No abstract available.

17.

Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analsysis of Moderate to Severe Chornic Plaque Psoriasis Trials.

Smiechowski B, Cope S.

Value Health. 2014 Nov;17(7):A544-5. doi: 10.1016/j.jval.2014.08.1762. Epub 2014 Oct 26. No abstract available.

18.

Critical Appraisal Of Network Meta-Analyses Evaluating The Efficacy And Safety Of New Oral Anticoagulants In Atrial Fibrillation Stroke Prevention Trials.

Cope S, Clemens A, Hammès F, Noack H, Jansen J.

Value Health. 2014 Nov;17(7):A475-6. doi: 10.1016/j.jval.2014.08.1362. Epub 2014 Oct 26. No abstract available.

19.

The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure.

Burnett H, Cope S, Vieira MC, Sagkriotis A, Senni M, Deschaseaux C.

Value Health. 2014 Nov;17(7):A327. doi: 10.1016/j.jval.2014.08.595. Epub 2014 Oct 26. No abstract available.

20.

Supplemental Content

Loading ...
Support Center